However, in our previous study, we reported that this NRP1-driven drug resistance was not dependent on VEGF-A [7], which is a major autocrine NRP-1 ligand implicated in sustaining viability and self-renewal of cancer cells. The gene discussed is VEGFA; the disease is cancer.